Healthcare and Pharmaceuticals industry

Global Newborn Screening Market Size Share Forecast 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Newborn screening programs test infants for disorders that are often not apparent at birth. Such disorders may be infectious, inherited, or caused by a medical problem in the mother. Early detection and treatment of some disorders can help prevent severe intellectual disability, health problems, growth problems, or even sudden infant death.
Furthermore, early disease diagnosis can reduce treatment cost. According to the Association of Public Health Laboratories 2012 report, the Medicaid cost of treating an infant with Severe Combined Immunodeficiency (SCID), which is fatal in the first two years of life without immune reconstitution, can reach US$ 2 million. However, if infants are diagnosed early, before developing life-threatening infections, from exposure to live childhood vaccines or common germs, they can be cured with a bone marrow transplant. The cost of the transplant is approximately US $100,000 when performed within the first 3.5 months of life.
Market Dynamics
Increasing number of newborn screenings, owing to rising awareness among parents and governments is expected to drive the newborn screening market growth. According to the Centers for Disease Control and Prevention (CDC) 2017, four million infants in the U.S. are routinely screened, using a few drops of blood from their heel, for certain endocrine, genetic, and metabolic disorders. The infants are also tested for hearing loss and Critical Congenital Heart Defects (CCHDs) prior to discharge from a hospital or birth center.
Furthermore, increasing incidence of hospital acquired diseases create an acute need for newborn screening. For instance, according to the Center for Disease Control and Prevention (CDC), in 2011, around one in every 25 infants was infected with at least one hospital acquired infections.
Government initiatives to support screening of newborns is also a major factor driving the newborn screening market. For instance, CDC is working to harness the latest advances in science and technology so that more disorders can be identified accurately and treated quickly. In 2005, CDC established the Newborn Screening Translation Research Initiative (NSTRI) with the CDC Foundation. NSTRI works with corporate, academic, and foundation partners to assure the quality of research methods during both pilot studies and routine screening.
However, lack of skilled professional, proper infrastructure and parent awareness in emerging regions are some of the major factors confining the newborn screening market. Moreover, the natural history for several diseases has not been well characterized and the effective follow-up and treatment may not be known. Excessive false-positive results of screening tests may produce additional costs to the healthcare system. However, improvements in newborn screening tests is expected to reduce number of false positives.
Key features of the study:

This report offers in-depth analysis of the global newborn screening market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the key players
It profiles key players in the global newborn screening market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Agilent Technologies, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., and ZenTech S.A.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global newborn screening market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for new born screening test market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Newborn Screening Market, By Product:

Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry

Global Newborn Screening Market, By Test:


Blood Test
Cardiac Test
Hearing Test
Urine Test


Global Newborn Screening Market, By Application:

Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder

Global Newborn Screening Market, By Region:

North America

By Country:

U.S.
Canada

By Product Type:

Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry

By Test:

Blood Test
Cardiac Test
Hearing Test
Urine Test

By Application:

Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder


Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Product Type:

Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry

By Test:

Blood Test
Cardiac Test
Hearing Test
Urine Test

By Application:

Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder


Asia Pacific

By Country:

Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific

By Product Type:

Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry

By Test:

Blood Test
Cardiac Test
Hearing Test
Urine Test

By Application:

Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder


Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

By Product Type:

Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry

By Test:

Blood Test
Cardiac Test
Hearing Test
Urine Test

By Application:

Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder


Middle East

By Country:

GCC
Israel
Rest of Middle East

By Product Type:

Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry

By Test:

Blood Test
Cardiac Test
Hearing Test
Urine Test

By Application:

Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder


Africa

By Country:

South Africa
Central Africa
North Africa

By Product Type:

Assay Kits
Hearing Screening Devices
Mass Spectrometer
Pulse Oximetry

By Test:

Blood Test
Cardiac Test
Hearing Test
Urine Test

By Application:

Blood Spot Disease
Critical Congenital Cardiac Disease
Maple Syrup Urine Disease
Hearing Disability
Sickle Cell Disease
Thyroid Disorder



Company Profiles

Agilent Technologies*

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

AB SCIEX
Bio-Rad Laboratories
Covidien PLC
GE Life Sciences
Masimo Corporation
Natus Medical Inc.
PerkinElmer Inc.
ZenTech S.A.


“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Product
o Market Snippet, By Test
o Market Snippet, By Application
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technological Advancements
o Regulatory Scenario
o Reimbursement Scenario
o PEST Analysis
4. Global Newborn Screening Market, By Product, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Assay Kits
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Hearing Screening Devices
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Mass Spectrometer
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Pulse Oximetry
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
5. Global Newborn Screening Market, By Application, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Blood Spot Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Critical Congenital Cardiac Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Maple Syrup Urine Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Hearing Disability
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Sickle Cell Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Thyroid Disorder
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
6. Global Newborn Screening Market, By Test, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Blood Test
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Cardiac Test
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Hearing Test
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
o Urine Test
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2026, (US$ Million)
7. Global Newborn Screening Market, By Region, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2017 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Product, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Test, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Agilent Technologies
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o AB SCIEX
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Bio-Rad Laboratories
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Covidien PLC
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o GE Life Sciences
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Masimo Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Natus Medical Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o PerkinElmer Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o ZenTech S.A.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 32 market data tables and 20 figures on "Newborn Screening Market" - Global forecast to 2026".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.